More MS news articles for May 2002

Decrease in heart ventricular ejection fraction during multiple sclerosis

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11985637&dopt=Abstract

Eur J Neurol 2002 May;9(3):287-91
Olindo S, Guillon B, Helias J, Phillibert B, Magne C, Feve JR.
Departments of Neurology, CHU G et R Laennec, Nantes, France, Departments of Nuclear Medicine, CHU G et R Laennec, Nantes, France.

Recent studies have shown that mitoxantrone is effective in patients with active multiple sclerosis (MS) and that cardiac monitoring is usually required

However, right and left ventricular ejection fractions (VEFs) have never been studied in MS patients as compared with control subjects

Radionuclide angiocardiography (RA) was performed to assess right and left VEFs at rest in 40 consecutive patients with active definite MS [15 men and 25 women; mean age 33.9 +/- 10 years; mean disease duration 8 +/- 6.5 years; 18 had relapsing-remitting and 22 had secondary progressive forms of the disease; mean Expanded Disability Status Scale (EDSS) score 4.8 +/- 1.9]

The control group consisted of 40 subjects free of neurological or cardiovascular disease (17 men and 23 women; 44.6 +/- 13.4 years of age)

The VEF values obtained in the control group defined the normal limits (right VEF 32-54%; left VEF 50-74%)

A statistically significant decrease of right (P=0.02) and left (P < 0.0001) VEFs was found in MS patients as compared with control subjects

RA showed pathological results for right (7.5%), left (10%) and both (7.5%) VEFs in 25% of MS patients

No correlation was found between VEF and sex, age, disease duration, disease course, EDSS score or previous treatment

Autonomic impairment, which frequently occurs in MS patients, may have accounted for the decrease in VEFs

Further physiological studies are required to determine factor responsible for the decrease of VEFs in MS.